Originally posted on publichealthwatch:
National Institutes of Health researchers reported on Wednesday that a possible vaccine for the Ebola virus appears to be safe in early testing and that a clinical study in West Africa can go ahead as planned late this year or in early 2015.
A look at the first group of people injected with the vaccine, which has been shown to protect monkeys from Ebola, shows no dangerous side effects. And it seems to be producing an immune response that would be expected to protect them from infection. The scientists reported the results of the Phase I testing in the New England Journal of Medicine on Wednesday.
“Based on these positive results from the first human trial of this candidate vaccine, we are continuing our accelerated plan for larger trials to determine if the vaccine is efficacious in preventing Ebola infection,” said Dr. Anthony S. Fauci, M.D., head of the National…
View original 788 more words